Patterns of Failure after Intensity-modulated Radiotherapy in Head and Neck Squamous Cell Carcinoma using Compartmental Clinical Target Volume Delineation

Clinical Oncology

Volumn 26, Issue 10, 2014, Pages 636-642

  Bayman, E ^a   Prestwich, R J D ^a   Speight, R ^a   Aspin, L ^a   Garratt, L ^a   Wilson, S ^a   Dyker, K E ^a   Sen, M ^a  

^a St James's Institute of Oncology   (United Kingdom)

Author keywords

Chemotherapy; Coregistration; Head and neck cancer; Intensity modulated radiotherapy; Recurrence pattern

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; DISTANT METASTASIS FREE SURVIVAL; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TONSIL CARCINOMA; TREATMENT FAILURE; TREATMENT PLANNING; TREATMENT RESPONSE; AGED; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; HEAD AND NECK NEOPLASMS; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; RADIATION DOSE; SURVIVAL RATE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT FAILURE;

EID: 84924085769     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2014.05.001     Document Type: Article

References (28)

1. O'Sullivan B., Rumble R.B., Warde P. Intensity-modulated radiotherapy in the treatment of head and neck cancer. Clin Oncol (R Coll Radiol) 2012, 24(7):474-487.
2. Nutting C.M., Morden J.P., Harrington K.J., et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011, 12(2):127-136.
3. Eisbruch A., Harris J., Garden A.S., et al. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys 2010, 76(5):1333-1338.
4. Njeh C.F. Tumor delineation: the weakest link in the search for accuracy in radiotherapy. JMed Phys 2008, 33(4):136-140.
5. Chen A.M., Farwell D.G., Luu Q., Chen L.M., Vijayakumar S., Purdy J.A. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2011, 80(5):1423-1429.
6. Hong T.S., Tome W.A., Harari P.M. Heterogeneity in head and neck IMRT target design and clinical practice. Radiother Oncol 2012, 103(1):92-98.
7. Pettit L., Hartley A., Bowden S.J., et al. Variation in volume definition between UK head and neck oncologists treating oropharyngeal carcinoma. Clin Oncol (R Coll Radiol) 2011, 23(9):654-655.
8. Caudell J.J., Meredith R.F., Spencer S.A., Keene K.S., Dobelbower M.C., Bonner J.A. Margin on gross tumor volume and risk of local recurrence in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010, 76(1):164-168.
9. Oksuz D.C., Prestwich R.J., Carey B., et al. Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy. Radiat Oncol 2011, 6(1):54.
10. Prestwich R.J., Oksuz D.C., Dyker K., Coyle C., Sen M. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic stage IV head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2011, 81(4):e237-243.
11. Prestwich R.J., Kancherla K., Oksuz D.C., et al. Asingle centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer. Radiat Oncol 2010, 5:121.
12. Gregoire V., Levendag P., Ang K.K., et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. Radiother Oncol 2003, 69(3):227-236.
13. Shakam A., Scrimger R., Liu D., et al. Dose-volume analysis of locoregional recurrences in head and neck IMRT, as determined by deformable registration: a prospective multi-institutional trial. Radiother Oncol 2011, 99(2):101-107.
14. Dawson L.A., Anzai Y., Marsh L., et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2000, 46(5):1117-1126.
15. Peters L.J., O'Sullivan B., Giralt J., et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. JClin Oncol 2010, 28(18):2996-3001.
16. Chao K.S., Wippold F.J., Ozyigit G., Tran B.N., Dempsey J.F. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 2002, 53(5):1174-1184.
17. Garden A.S., Dong L., Morrison W.H., et al. Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 2013, 85(4):941-947.
18. Gupta T., Jain S., Agarwal J.P., et al. Prospective assessment of patterns of failure after high-precision definitive (chemo)radiation in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2011, 80(2):522-531.
19. Yao M., Dornfeld K.J., Buatti J.M., et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma - the University of Iowa experience. Int J Radiat Oncol Biol Phys 2005, 63(2):410-421.
20. Miah A.B., Bhide S.A., Guerrero-Urbano M.T., et al. Dose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers. Int J Radiat Oncol Biol Phys 2012, 82(2):539-547.
21. Raktoe S.A., Dehnad H., Raaijmakers C.P., Braunius W., Terhaard C.H. Origin of tumor recurrence after intensity modulated radiation therapy for oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2013, 85(1):136-141.
22. Eisbruch A., Marsh L.H., Dawson L.A., et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 2004, 59(1):28-42.
23. Ang K.K., Harris J., Wheeler R., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. NEngl J Med 2010, 363(1):24-35.
24. Chao K.S., Ozyigit G., Tran B.N., Cengiz M., Dempsey J.F., Low D.A. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003, 55(2):312-321.
25. Studer G., Luetolf U.M., Glanzmann C. Locoregional failure analysis in head-and-neck cancer patients treated with IMRT. Strahlenther Onkol 2007, 183(8):417-423. discussion 24-25.
26. Schoenfeld G.O., Amdur R.J., Morris C.G., Li J.G., Hinerman R.W., Mendenhall W.M. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008, 71(2):377-385.
27. Daly M.E., Le Q.T., Maxim P.G., et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 2010, 76(5):1339-1346.
28. Loo S.W., Geropantas K., Wilson P., Martin W.M., Roques T.W. Target volume definition for intensity-modulated radiotherapy after induction chemotherapy and patterns of treatment failure after sequential chemoradiotherapy in locoregionally advanced oropharyngeal squamous cell carcinoma. Clin Oncol (R Coll Radiol) 2013, 25(3):162-170.